Research

Latest news

FDA Approves Ardelyx's Kidney Disease-Related Drug

FDA Approves Ardelyx's Kidney Disease-Related Drug

2023-10-27

The U.S. Food and Drug Administration (FDA) has approved Ardelyx's drug to treat high phosphate levels in patients with chronic kidney disease (CKD), the company said on Tuesday, more than two years after it was initially rejected.

READ MORE

Drug-delivery technique for brain cancer shows growing promise

Drug-delivery technique for brain cancer shows growing promise

2023-10-18

A technique developed by University of Texas at Dallas and UT Southwestern Medical Center researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, the most common human brain cancer.

READ MORE

Gut Microbiome Variations May Be Predictive of Precancerous Colonic Lesions, CRC

Gut Microbiome Variations May Be Predictive of Precancerous Colonic Lesions, CRC

2023-10-16

People with precancerous colonic lesions show significant differences in their gut microbiome compared to the general population up to 5 years before the lesions develop, according to a large, 22-year analysis from the Dutch Microbiome Project cohort study.

READ MORE

European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata

European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata

2023-09-19

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for LITFULO™ (ritlecitinib) to treat adults and adolescents 12 years of age and older with severe alopecia areata.

READ MORE

< 1 2 > proceed page